Prospective multicenter study of camrelizumab in real-world settings for asian patients with esophageal squamous cell carcinoma

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2024-11-18
DOI
https://doi.org/10.1186/s12885-024-13196-4
Citations
3
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
1.72
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prospective multicenter study of camrelizumab in real-world settings for asian patients with esophageal squamous cell carcinoma

Dongmei Ke, Yifan Dai, Qunrong Cai, Tingting Li et al.
3 citations
BMC Cancer
Esophageal Cancer Research and Treatment
1.72
article

Prospective multicenter study of camrelizumab in real-world settings for asian patients with esophageal squamous cell carcinoma

Dongmei Ke, Yifan Dai, Qunrong Cai, Tingting Li, Jiancheng Li, Qiwei Yao, Xiaobin Fu
article en
3 citations

Abstract

No abstract available for this paper.
BMC CancerVol. 24(1)
Fujian Medical University (CN), First Affiliated Hospital of Xiamen University (CN), Second Affiliated Hospital of Fujian Medical University (CN), Fujian Provincial Cancer Hospital (CN)
No poverty
Openalex Percentile: Top 14%
Esophageal Cancer Research and Treatment
1.72
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Prospective multicenter study of camrelizumab in real-world settings for asian patients with esophageal squamous cell carcinoma — Dongmei Ke, Yifan Dai, et al. · BMC Cancer (2024) | TGRS Research Map | TGRS